| Term | Count | % | | DRUG INEFFECTIVE | 4000 | 9.23% |
| TREATMENT FAILURE | 3069 | 7.08% |
| OCULAR HYPERAEMIA | 2284 | 5.27% |
| EYE IRRITATION | 1781 | 4.11% |
| MADAROSIS | 1369 | 3.16% |
| EYE PRURITUS | 1299 | 3.00% |
| ERYTHEMA OF EYELID | 1004 | 2.32% |
| EYE PAIN | 874 | 2.02% |
| HYPERSENSITIVITY | 839 | 1.94% |
| VISION BLURRED | 806 | 1.86% |
| INTRAOCULAR PRESSURE INCREASED | 695 | 1.60% |
| FATIGUE | 659 | 1.52% |
| OFF LABEL USE | 651 | 1.50% |
| HEADACHE | 632 | 1.46% |
| EYE SWELLING | 629 | 1.45% |
| DRY EYE | 626 | 1.44% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 577 | 1.33% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.24% |
| EYELIDS PRURITUS | 527 | 1.22% |
| DYSPNOEA | 512 | 1.18% |
| ERYTHEMA | 499 | 1.15% |
| DIZZINESS | 494 | 1.14% |
| INCORRECT DOSE ADMINISTERED | 481 | 1.11% |
| SKIN HYPERPIGMENTATION | 480 | 1.11% |
| NAUSEA | 466 | 1.08% |
| DIARRHOEA | 462 | 1.07% |
| FALL | 433 | 1.00% |
| VISUAL IMPAIRMENT | 432 | 1.00% |
| ASTHENIA | 421 | 0.97% |
| EYELID OEDEMA | 419 | 0.97% |
| PRURITUS | 406 | 0.94% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.93% |
| PAIN | 371 | 0.86% |
| EYELID IRRITATION | 365 | 0.84% |
| LACRIMATION INCREASED | 364 | 0.84% |
| DEATH | 352 | 0.81% |
| RASH | 334 | 0.77% |
| PRODUCT DOSE OMISSION ISSUE | 331 | 0.76% |
| CATARACT | 323 | 0.75% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 311 | 0.72% |
| GLAUCOMA | 305 | 0.70% |
| EYE DISCHARGE | 299 | 0.69% |
| MALAISE | 297 | 0.69% |
| THERAPEUTIC RESPONSE DECREASED | 296 | 0.68% |
| GROWTH OF EYELASHES | 293 | 0.68% |
| SKIN DISCOLOURATION | 283 | 0.65% |
| VISUAL ACUITY REDUCED | 282 | 0.65% |
| TRICHORRHEXIS | 281 | 0.65% |
| BLEPHARAL PIGMENTATION | 278 | 0.64% |
| DRUG DOSE OMISSION | 272 | 0.63% |
| PNEUMONIA | 264 | 0.61% |
| VOMITING | 257 | 0.59% |
| ARTHRALGIA | 255 | 0.59% |
| PAIN IN EXTREMITY | 254 | 0.59% |
| COUGH | 245 | 0.57% |
| DRUG HYPERSENSITIVITY | 245 | 0.57% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 240 | 0.55% |
| WEIGHT DECREASED | 235 | 0.54% |
| PRODUCT QUALITY ISSUE | 233 | 0.54% |
| INSOMNIA | 230 | 0.53% |
| HYPERTENSION | 229 | 0.53% |
| EYE DISORDER | 213 | 0.49% |
| FOREIGN BODY SENSATION IN EYES | 206 | 0.48% |
| DECREASED APPETITE | 196 | 0.45% |
| BACK PAIN | 191 | 0.44% |
| HAIR GROWTH ABNORMAL | 187 | 0.43% |
| CONSTIPATION | 186 | 0.43% |
| PRODUCT PACKAGING QUANTITY ISSUE | 185 | 0.43% |
| BLOOD PRESSURE INCREASED | 184 | 0.42% |
| OCULAR DISCOMFORT | 183 | 0.42% |
| ANAEMIA | 182 | 0.42% |
| GAIT DISTURBANCE | 179 | 0.41% |
| ANXIETY | 173 | 0.40% |
| HYPOTENSION | 170 | 0.39% |
| PYREXIA | 168 | 0.39% |
| CONDITION AGGRAVATED | 165 | 0.38% |
| FEELING ABNORMAL | 163 | 0.38% |
| PHOTOPHOBIA | 160 | 0.37% |
| URINARY TRACT INFECTION | 154 | 0.36% |
| DEPRESSION | 151 | 0.35% |
| CONFUSIONAL STATE | 149 | 0.34% |
| EXPIRED PRODUCT ADMINISTERED | 149 | 0.34% |
| SOMNOLENCE | 149 | 0.34% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.34% |
| MYALGIA | 146 | 0.34% |
| SWELLING OF EYELID | 146 | 0.34% |
| OEDEMA PERIPHERAL | 145 | 0.33% |
| PERIPHERAL SWELLING | 145 | 0.33% |
| ABDOMINAL DISCOMFORT | 143 | 0.33% |
| BLINDNESS | 143 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 143 | 0.33% |
| CHEST PAIN | 143 | 0.33% |
| BURNING SENSATION | 140 | 0.32% |
| EYELID PAIN | 140 | 0.32% |
| BLEPHARITIS | 139 | 0.32% |
| BLOOD GLUCOSE INCREASED | 139 | 0.32% |
| NASOPHARYNGITIS | 138 | 0.32% |
| WEIGHT INCREASED | 137 | 0.32% |
| ALOPECIA | 136 | 0.31% |
| ABDOMINAL PAIN UPPER | 134 | 0.31% |
| Total | 43341 | |